Picture of Vitrolife AB logo

VITR — Vitrolife AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Vitrolife Q1 EBITDA Falls To SEK 116 Million

April 23 (Reuters) - Vitrolife AB  VITR.ST :
    * MARCH 2020: GOOD GROWTH BUT UNCERTAIN SECOND QUARTER
    * Q1 SALES AMOUNTED TO SEK 334 (312) MILLION, CORRESPONDING
TO AN
INCREASE OF 7 PERCENT IN SEK
    * Q1 EBITDA SEK 116 MILLION VERSUS SEK 126 MILLION YEAR AGO
    * DUE TO GREAT UNCERTAINTY PREVAILING FROM EXTENSIVE SPREAD
OF
COVID-19, VITROLIFE'S BOARD DECIDED TO POSTPONE ANNUAL GENERAL
MEETING TO A LATER DATE
    * LARGE REDUCTION IN INFLOW OF ORDERS DUE TO COVID-19 DURING
BEGINNING OF Q2
    * SALES DURING FIRST WEEKS OF APRIL AMOUNTED TO
APPROXIMATELY A
THIRD OF THOSE IN CORRESPONDING PERIOD PREVIOUS YEAR

Source text for Eikon:  ID:nWkr1pQyK4 
Further company coverage:  VITR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Vitrolife AB

See all news